Insider · CIK 0001420987

Schoeneck James A

CIK 0001420987 Name as filed on the most recent filing

Filed as Schoeneck James A (16)

27 transaction lines · from 16 filings · filed 2011-08-24 to 2025-08-25 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

27 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-08-21 P, Open-market purchase Calidi Biotherapeutics, Inc.CLDI 150,000, acquired Open Form 4 filing 0001641172-25-025448
2025-06-30 P, Open-market purchase Fibrogen IncFGEN 119,485, acquired Open Form 4 filing 0001415889-25-019067
2025-03-21 P, Open-market purchase Fibrogen IncFGEN 17,040, acquired Open Form 4 filing 0001415889-25-008823
2025-03-20 P, Open-market purchase Fibrogen IncFGEN 88,000, acquired Open Form 4 filing 0001415889-25-008823
2023-06-07 S, Open-market sale Fibrogen IncFGEN 127,987, disposed Open Form 4 filing 0001209191-23-036073
2019-05-07 S, Open-market sale Fibrogen IncFGEN 2 lines 94,045, disposed Open Form 4 filing 0001209191-19-028663
2019-04-08 S, Open-market sale Fibrogen IncFGEN 105,800, disposed Open Form 4 filing 0001209191-19-024314
2019-03-07 S, Open-market sale Fibrogen IncFGEN 2 lines 109,472, disposed Open Form 4 filing 0001209191-19-018278
2019-02-07 S, Open-market sale Fibrogen IncFGEN 114,340, disposed Open Form 4 filing 0001209191-19-008746
2019-01-07 S, Open-market sale Fibrogen IncFGEN 91,800, disposed Open Form 4 filing 0001209191-19-003154
2018-07-03 S, Open-market sale Fibrogen IncFGEN 496,535, disposed Open Form 4 filing 0001209191-18-041916
2018-06-22 S, Open-market sale Fibrogen IncFGEN 283,465, disposed Open Form 4 filing 0001209191-18-039547
2014-12-02 S, Open-market sale Depomed IncDEPO 582,233, disposed Open Form 4 filing 0001179110-14-017513
2014-03-14 S, Open-market sale Depomed IncDEPO 247,124, disposed Open Form 4 filing 0001179110-14-005240
2013-12-02 S, Open-market sale Depomed IncDEPO 144,454, disposed Open Form 4 filing 0001179110-13-017420
2013-05-10 P, Open-market purchase Depomed IncDEPO 127,633, acquired Open Form 4 filing 0001179110-13-008238
2011-08-23 P, Open-market purchase Depomed IncDEPO 9 lines 102,582, acquired Open Form 4 filing 0001179110-11-012553

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 14
  • Open-market sale 13
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Schoeneck James A, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001420987

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.